Peiyan Kong

机构：Army Medical University, Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0003-3662-3990

发表论文 164 篇 · 总被引 1624 次 · h-index 22

代表论文

• Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant (2023 · JAMA Oncology · 被引 60)
• Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme (2023 · Annals of Hematology · 被引 11)
• Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia (2023 · Cancer Medicine · 被引 10)
• Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation (2023 · Current Medical Science · 被引 9)
• Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial (2025 · American Journal of Hematology · 被引 6)
• Thrombopoietin receptor agonists for refractory thrombocytopenia in patients after autologous hematopoietic stem cell transplantation (2023 · Transplant Immunology · 被引 5)